Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 178

Similar articles for PubMed (Select 11254696)

2.

The effects of ITIM-bearing FcgammaRIIB on the nuclear shuttling of MAP kinase in RBL-2H3 cells.

Ohyama N, Furuno T, Hirashima N, Nakanishi M.

Immunol Lett. 2003 Dec 15;90(2-3):173-6.

PMID:
14687721
3.

Examining the mechanism of Erk nuclear translocation using green fluorescent protein.

Horgan AM, Stork PJ.

Exp Cell Res. 2003 May 1;285(2):208-20.

PMID:
12706116
4.

Dynamic regulation of ERK2 nuclear translocation and mobility in living cells.

Costa M, Marchi M, Cardarelli F, Roy A, Beltram F, Maffei L, Ratto GM.

J Cell Sci. 2006 Dec 1;119(Pt 23):4952-63. Epub 2006 Nov 14.

5.
6.
7.

Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling.

Pouysségur J, Volmat V, Lenormand P.

Biochem Pharmacol. 2002 Sep;64(5-6):755-63. Review.

PMID:
12213567
8.
9.

A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation.

Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH.

Curr Biol. 1998 Oct 22;8(21):1141-50.

10.

Identification of a cytoplasmic-retention sequence in ERK2.

Rubinfeld H, Hanoch T, Seger R.

J Biol Chem. 1999 Oct 22;274(43):30349-52.

11.

The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions.

Whitehurst AW, Robinson FL, Moore MS, Cobb MH.

J Biol Chem. 2004 Mar 26;279(13):12840-7. Epub 2004 Jan 5.

12.

Cytoplasmic localization of the mitogen-activated protein kinase activator MEK.

Zheng CF, Guan KL.

J Biol Chem. 1994 Aug 5;269(31):19947-52.

13.

Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.

Robinson FL, Whitehurst AW, Raman M, Cobb MH.

J Biol Chem. 2002 Apr 26;277(17):14844-52. Epub 2002 Jan 31.

14.
15.

ERK2 enters the nucleus by a carrier-independent mechanism.

Whitehurst AW, Wilsbacher JL, You Y, Luby-Phelps K, Moore MS, Cobb MH.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7496-501.

18.
19.

Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1.

Yao Z, Flash I, Raviv Z, Yung Y, Asscher Y, Pleban S, Seger R.

Oncogene. 2001 Nov 15;20(52):7588-96.

20.

Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility.

Tanimura S, Nomura K, Ozaki K, Tsujimoto M, Kondo T, Kohno M.

J Biol Chem. 2002 Aug 2;277(31):28256-64. Epub 2002 May 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk